{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T10:42:18Z","timestamp":1787740938508,"version":"build-2784847793"},"reference-count":173,"publisher":"Elsevier BV","issue":"3-4","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004710","name":"Fondazione Umberto Veronesi","doi-asserted-by":"publisher","award":["2022"],"award-info":[{"award-number":["2022"]}],"id":[{"id":"10.13039\/501100004710","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Oncology"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1053\/j.seminoncol.2024.05.001","type":"journal-article","created":{"date-parts":[[2024,5,20]],"date-time":"2024-05-20T16:01:04Z","timestamp":1716220864000},"page":"106-122","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Invasive lobular breast cancer: Focus on prevention, genetics, diagnosis, and treatment"],"prefix":"10.1053","volume":"51","author":[{"given":"Giovanni","family":"Corso","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Fusco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Guerini-Rocco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Cristina","family":"Leonardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Criscitiello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Zagami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleonora","family":"Nicol\u00f2","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Mazzarol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"La Vecchia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filippo","family":"Pesapane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Zanzottera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Tarantino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Petitto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatrice","family":"Bianchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Massari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Boato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Sibilio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Polizzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Curigliano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra Margherita","family":"De Scalzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Lauria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernardo","family":"Bonanni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Marabelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Rotili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Nicosia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana","family":"Albini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariarosaria","family":"Calvello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita A.","family":"Mukhtar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark E.","family":"Robson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virgilio","family":"Sacchini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gad","family":"Rennert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viviana","family":"Galimberti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Veronesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9208-988X","authenticated-orcid":false,"given":"Francesca","family":"Magnoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1053\/j.seminoncol.2024.05.001_bib0001","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1097\/CEJ.0000000000000712","article-title":"Cancer mortality in Italian populations: differences between Italy and the USA","volume":"31","author":"Santucci","year":"2022","journal-title":"Eur J Cancer Prev"},{"key":"10.1053\/j.seminoncol.2024.05.001_bib0002","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1093\/annonc\/mdz051","article-title":"European cancer mortality predictions for the year 2019 with focus on breast cancer","volume":"30","author":"Malvezzi","year":"2019","journal-title":"Ann Oncol"},{"key":"10.1053\/j.seminoncol.2024.05.001_bib0003","doi-asserted-by":"crossref","first-page":"4165","DOI":"10.3390\/ijerph17114165","article-title":"Geographic inequalities in breast cancer in Italy: trend analysis of mortality and risk factors","volume":"17","author":"Rossi","year":"2020","journal-title":"Int J Environ Res Public Health"},{"key":"10.1053\/j.seminoncol.2024.05.001_bib0004","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1038\/s41571-020-0378-y","article-title":"The changing landscape of cancer in the USA\u2014opportunities for advancing prevention and treatment","volume":"17","author":"Islami","year":"2020","journal-title":"Nat Rev Clin Oncol"},{"issue":"4","key":"10.1053\/j.seminoncol.2024.05.001_bib0005","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1186\/bcr1275","article-title":"Mammary epithelial cell transformation: insights from cell culture and mouse models","volume":"7","author":"Dimri","year":"2005","journal-title":"Breast Cancer Res BCR"},{"issue":"8","key":"10.1053\/j.seminoncol.2024.05.001_bib0006","doi-asserted-by":"crossref","first-page":"e386","DOI":"10.1016\/S1470-2045(20)30219-9","article-title":"Hereditary diffuse gastric cancer: updated clinical practice guidelines","volume":"21","author":"Blair","year":"2020","journal-title":"Lancet Oncol"},{"key":"10.1053\/j.seminoncol.2024.05.001_bib0007","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s12282-020-01146-4","article-title":"The prognosis of invasive ductal carcinoma, lobular carcinoma and mixed ductal and lobular carcinoma according to molecular subtypes of the breast","volume":"28","author":"Zhao","year":"2021","journal-title":"Breast Cancer"},{"issue":"1","key":"10.1053\/j.seminoncol.2024.05.001_bib0008","doi-asserted-by":"crossref","first-page":"7205","DOI":"10.1038\/s41598-018-25357-0","article-title":"Invasive lobular and ductal breast carcinoma differ in immune response, protein translation efficiency and metabolism","volume":"8","author":"Du","year":"2018","journal-title":"Sci Rep"},{"key":"10.1053\/j.seminoncol.2024.05.001_bib0009","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s40487-019-00105-0","article-title":"Invasive lobular breast cancer as a distinct disease: implications for therapeutic strategy","volume":"8","author":"Luveta","year":"2019","journal-title":"Oncol Ther"},{"key":"10.1053\/j.seminoncol.2024.05.001_bib0010","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1245\/s10434-009-0402-z","article-title":"Neoadjuvant chemotherapy in invasive lobular carcinoma may not improve rates of breast conservation","volume":"16","author":"Boughey","year":"2009","journal-title":"Ann Surg Oncol"},{"key":"10.1053\/j.seminoncol.2024.05.001_bib0011","first-page":"18","article-title":"Collective wisdom: lobular carcinoma of the breast","volume":"35","author":"Sledge","year":"2016","journal-title":"Am Soc Clin Oncol"},{"key":"10.1053\/j.seminoncol.2024.05.001_bib0012","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3322\/caac.21492","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"10.1053\/j.seminoncol.2024.05.001_bib0013","first-page":"491","article-title":"Lobular carcinoma in situ: a rare form of mammary cancer","volume":"17","author":"Foote","year":"1941","journal-title":"Am J Pathol"},{"key":"10.1053\/j.seminoncol.2024.05.001_bib0014","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s13058-020-01384-6","article-title":"Invasive lobular carcinoma of the breast: the increasing importance of this special subtype","volume":"23","author":"McCart Reed","year":"2021","journal-title":"Breast Cancer Res"},{"key":"10.1053\/j.seminoncol.2024.05.001_bib0015","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.annonc.2022.05.006","article-title":"Current and future diagnostic and treatment strategies for patients with invasive lobular breast cancer","volume":"33","author":"Van Baelen","year":"2022","journal-title":"Ann Oncol"},{"key":"10.1053\/j.seminoncol.2024.05.001_bib0016","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1001\/jama.289.11.1421","article-title":"Trends in incidence rates of invasive lobular and ductal breast carcinoma","volume":"289","author":"Li","year":"2003","journal-title":"JAMA"},{"key":"10.1053\/j.seminoncol.2024.05.001_bib0017","doi-asserted-by":"crossref","first-page":"3006","DOI":"10.1200\/JCO.2007.14.9336","article-title":"International Breast Cancer Study Group. Distinct clinical and prognostic features of infiltrating lobular carcinoma of the breast: combined results of 15 International Breast Cancer Study Group clinical trials","volume":"26","author":"Pestalozzi","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2024.05.001_bib0018","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.590643","article-title":"Comparison of overall survival between invasive lobular breast carcinoma and invasive ductal breast carcinoma: a propensity score matching study based on SEER database","volume":"10","author":"Yang","year":"2020","journal-title":"Front Oncol"},{"key":"10.1053\/j.seminoncol.2024.05.001_bib0019","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s10549-022-06572-w","article-title":"Invasive lobular carcinoma: an understudied emergent subtype of breast cancer","volume":"193","author":"Mouabbi","year":"2022","journal-title":"Breast Cancer Res Treat"},{"key":"10.1053\/j.seminoncol.2024.05.001_bib0020","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1158\/1055-9965.EPI-10-0188","article-title":"Risk factors for ductal, lobular, and mixed ductal-lobular breast cancer in a screening population","volume":"19","author":"Phipps","year":"2010","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1053\/j.seminoncol.2024.05.001_bib0021","doi-asserted-by":"crossref","first-page":"R106","DOI":"10.1186\/bcr2790","article-title":"Risk factors for ductal and lobular breast cancer: results from the nurses' health study","volume":"12","author":"Kotsopoulos","year":"2010","journal-title":"Breast Cancer Res"},{"key":"10.1053\/j.seminoncol.2024.05.001_bib0022","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.1002\/cncr.30644","article-title":"Breast cancer prevention strategies in lobular carcinoma in situ: a decision analysis","volume":"123","author":"Wong","year":"2017","journal-title":"Cancer"},{"key":"10.1053\/j.seminoncol.2024.05.001_bib0023","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s12672-017-0297-2","article-title":"Alcohol intake and risk of breast cancer by histologic subtype and estrogen receptor status among women aged 55 to 74 years","volume":"8","author":"Baglia","year":"2017","journal-title":"Horm Cancer"},{"key":"10.1053\/j.seminoncol.2024.05.001_bib0024","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1093\/jnci\/djq316","article-title":"Alcohol consumption and risk of postmenopausal breast cancer by subtype: the women's health initiative observational study","volume":"102","author":"Li","year":"2010","journal-title":"J Natl Cancer Inst"},{"key":"10.1053\/j.seminoncol.2024.05.001_bib0025","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1093\/aje\/kwu189","article-title":"Alcohol and risk of breast cancer in postmenopausal women: an analysis of etiological heterogeneity by multiple tumor characteristics","volume":"180","author":"Falk","year":"2014","journal-title":"Am J Epidemiol"},{"key":"10.1053\/j.seminoncol.2024.05.001_bib0026","doi-asserted-by":"crossref","first-page":"e55374","DOI":"10.1371\/journal.pone.0055374","article-title":"Mediterranean dietary pattern and risk of breast cancer","volume":"8","author":"Couto","year":"2013","journal-title":"PLoS One"},{"key":"10.1053\/j.seminoncol.2024.05.001_bib0027","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1038\/ejcn.2011.69","article-title":"Does the Mediterranean dietary pattern or the Healthy Diet Index influence the risk of breast cancer in a large British cohort of women?","volume":"65","author":"Cade","year":"2011","journal-title":"Eur J Clin Nutr"},{"key":"10.1053\/j.seminoncol.2024.05.001_bib0028","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.3945\/ajcn.2009.28796","article-title":"Dietary patterns and breast cancer risk: a systematic review and meta-analysis","volume":"91","author":"Brennan","year":"2010","journal-title":"Am J Clin Nutr"},{"key":"10.1053\/j.seminoncol.2024.05.001_bib0029","doi-asserted-by":"crossref","first-page":"e516","DOI":"10.1016\/j.clbc.2020.03.007","article-title":"Dietary patterns and risk of invasive ductal and lobular breast carcinomas: a systematic review and meta-analysis","volume":"20","author":"Dianatinasab","year":"2020","journal-title":"Clin Breast Cancer"},{"issue":"12","key":"10.1053\/j.seminoncol.2024.05.001_bib0030","doi-asserted-by":"crossref","first-page":"5859","DOI":"10.1038\/s41598-022-09725-5","article-title":"Adherence to a western dietary pattern and risk of invasive ductal and lobular breast carcinomas: a case-control study","volume":"7","author":"Foroozani","year":"2022","journal-title":"Sci Rep"},{"key":"10.1053\/j.seminoncol.2024.05.001_bib0031","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1093\/aje\/kwp257","article-title":"Postmenopausal breast cancer risk and dietary patterns in the E3N-EPIC prospective cohort study","volume":"170","author":"Cottet","year":"2009","journal-title":"Am J Epidemiol"},{"key":"10.1053\/j.seminoncol.2024.05.001_bib0032","doi-asserted-by":"crossref","first-page":"664","DOI":"10.3945\/ajcn.2009.27758","article-title":"Dietary fiber intake and risk of breast cancer in postmenopausal women: the National Institutes of Health-AARP Diet and Health Study","volume":"90","author":"Park","year":"2009","journal-title":"Am J Clin Nutr"},{"key":"10.1053\/j.seminoncol.2024.05.001_bib0033","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1097\/CEJ.0b013e32833ade68","article-title":"Micronutrient intake and breast cancer characteristics among postmenopausal women","volume":"19","author":"Roswall","year":"2010","journal-title":"Eur J Cancer Prev"},{"key":"10.1053\/j.seminoncol.2024.05.001_bib0034","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1158\/1055-9965.EPI-21-0837","article-title":"A metabolomics analysis of circulating carotenoids and breast cancer risk","volume":"31","author":"Peng","year":"2022","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1053\/j.seminoncol.2024.05.001_bib0035","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1158\/1055-9965.EPI-10-0318","article-title":"Specialty supplements and breast cancer risk in the VITamins and Lifestyle (VITAL) Cohort","volume":"19","author":"Brasky","year":"2010","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"10","key":"10.1053\/j.seminoncol.2024.05.001_bib0036","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1038\/sj.bjc.6604853","article-title":"Million women study collaborators. Reproductive factors and specific histological types of breast cancer: prospective study and meta-analysis","volume":"100","author":"Reeves","year":"2009","journal-title":"Br J Cancer"},{"key":"10.1053\/j.seminoncol.2024.05.001_bib0037","article-title":"Lobular breast cancer: a review","volume":"10","author":"Wilson","year":"2010","journal-title":"Front Oncol"},{"key":"10.1053\/j.seminoncol.2024.05.001_bib0038","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s10689-015-9833-9","article-title":"Is there an association between invasive lobular carcinoma of the breast and a family history of gastric cancer?","volume":"15","author":"Chikman","year":"2016","journal-title":"Fam Cancer"},{"key":"10.1053\/j.seminoncol.2024.05.001_bib0039","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1002\/ijc.21236","article-title":"Lobular breast cancer: excess familiarity observed in the Utah Population Database","volume":"117","author":"Allen-Brady","year":"2020","journal-title":"Int J Cancer"},{"key":"10.1053\/j.seminoncol.2024.05.001_bib0040","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1002\/ijc.11713","article-title":"Familial association of histology specific breast cancers with cancers at other sites","volume":"109","author":"Lorenzo Bermejo","year":"2004","journal-title":"Int J Cancer"},{"key":"10.1053\/j.seminoncol.2024.05.001_bib0041","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1004285","article-title":"Genetic predisposition to in situ and invasive lobular carcinoma of the breast","volume":"10","author":"Sawyer","year":"2014","journal-title":"PLoS Genet"},{"key":"10.1053\/j.seminoncol.2024.05.001_bib0042","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1158\/1055-9965.EPI-18-1102","article-title":"Frequency of pathogenic germline variants in CDH1, BRCA2, CHEK2, PALB2, BRCA1, and TP53 in sporadic lobular breast cancer","volume":"28","author":"Petridis","year":"2019","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1053\/j.seminoncol.2024.05.001_bib0043","doi-asserted-by":"crossref","first-page":"3918","DOI":"10.1200\/JCO.21.00640","article-title":"Germline pathogenic variants in cancer predisposition genes among women with invasive lobular carcinoma of the breast","volume":"39","author":"Yadav","year":"2021","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2024.05.001_bib0044","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1136\/jmedgenet-2018-105337","article-title":"Hereditary lobular breast cancer with an emphasis on E-cadherin genetic defect","volume":"55","author":"Van Diest","year":"2018","journal-title":"J Med Genet"},{"key":"10.1053\/j.seminoncol.2024.05.001_bib0045","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1001\/jamaoncol.2014.168","article-title":"Hereditary diffuse gastric cancer syndrome: CDH1 mutations and beyond","volume":"1","author":"Hansford","year":"2015","journal-title":"JAMA Oncol"},{"issue":"3","key":"10.1053\/j.seminoncol.2024.05.001_bib0046","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1097\/CEJ.0000000000000688","article-title":"CDH1 germline mutations in families with hereditary lobular breast cancer","volume":"31","author":"Girardi","year":"2022","journal-title":"Eur J Cancer Prev"},{"key":"10.1053\/j.seminoncol.2024.05.001_bib0047","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/j.1365-2559.2006.02419.x","article-title":"Laboratory handling and histology reporting of breast specimens from patients who have received neoadjuvant chemotherapy","volume":"50","author":"Pinder","year":"2007","journal-title":"Histopathology"},{"key":"10.1053\/j.seminoncol.2024.05.001_bib0048","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1097\/PAS.0b013e3182918a2b","article-title":"Lobular neoplasia of the breast revisited with emphasis on the role of E-cadherin immunohistochemistry","volume":"37","author":"Dabbs","year":"2013","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.seminoncol.2024.05.001_bib0049","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/j.1365-2559.2007.02891.x","article-title":"In situ and invasive lobular neoplasia of the breast","volume":"52","author":"Hanby","year":"2008","journal-title":"Histopathology"},{"key":"10.1053\/j.seminoncol.2024.05.001_bib0050","doi-asserted-by":"crossref","first-page":"5930","DOI":"10.1111\/jcmm.15140","article-title":"E-cadherin deregulation in breast cancer","volume":"24","author":"Corso","year":"2020","journal-title":"J Cell Mol Med"},{"issue":"2","key":"10.1053\/j.seminoncol.2024.05.001_bib0051","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/his.14091","article-title":"The 2019 World Health Organization classification of tumours of the breast","volume":"77","author":"Tan","year":"2020","journal-title":"Histopathology"},{"key":"10.1053\/j.seminoncol.2024.05.001_bib0052","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1002\/path.2655","article-title":"A tissue reconstitution model to study cancer cell-intrinsic and -extrinsic factors in mammary tumourigenesis","volume":"220","author":"Evers","year":"2010","journal-title":"J Pathol"},{"issue":"8","key":"10.1053\/j.seminoncol.2024.05.001_bib0053","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1016\/j.celrep.2016.07.059","article-title":"PTEN loss in E-cadherin-deficient mouse mammary epithelial cells rescues apoptosis and results in development of classical invasive lobular carcinoma","volume":"16","author":"Boelens","year":"2016","journal-title":"Cell Rep"},{"issue":"6","key":"10.1053\/j.seminoncol.2024.05.001_bib0054","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/j.1365-2559.1979.tb03029.x","article-title":"Invasive lobular carcinoma of the breast: incidence and variants","volume":"3","author":"Martinez","year":"1979","journal-title":"Histopathology"},{"issue":"1","key":"10.1053\/j.seminoncol.2024.05.001_bib0055","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/his.14829","article-title":"Update on lobular lesions of the breast","volume":"82","author":"Kuba","year":"2023","journal-title":"Histopathology"},{"key":"10.1053\/j.seminoncol.2024.05.001_bib0056","first-page":"74","article-title":"A histologic classification of carcinoma of the breast","volume":"19","author":"Foote","year":"1946","journal-title":"Surgery"},{"issue":"4","key":"10.1053\/j.seminoncol.2024.05.001_bib0057","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1002\/1097-0142(196904)23:4<840::AID-CNCR2820230418>3.0.CO;2-1","article-title":"Lobular carcinoma of the breast","volume":"23","author":"Warner","year":"1969","journal-title":"Cancer"},{"issue":"2","key":"10.1053\/j.seminoncol.2024.05.001_bib0058","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1097\/00000658-196608000-00018","article-title":"Lobular carcinoma of the female breast. Report of 73 cases","volume":"164","author":"Newman","year":"1966","journal-title":"Ann Surg"},{"issue":"2","key":"10.1053\/j.seminoncol.2024.05.001_bib0059","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1365-2559.1982.tb02712.x","article-title":"Infiltrating lobular carcinoma of the breast","volume":"6","author":"Dixon","year":"1982","journal-title":"Histopathology"},{"issue":"1","key":"10.1053\/j.seminoncol.2024.05.001_bib0060","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1097\/00000478-199001000-00002","article-title":"Prognosis in infiltrating lobular carcinoma. An analysis of \u201cclassical\u201d and variant tumors","volume":"14","author":"DiCostanzo","year":"1990","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"10.1053\/j.seminoncol.2024.05.001_bib0061","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1097\/01.pas.0000213368.41251.b9","article-title":"High frequency of coexistence of columnar cell lesions, lobular neoplasia, and low-grade ductal carcinoma in situ with invasive tubular carcinoma and invasive lobular carcinoma","volume":"31","author":"Abdel-Fatah","year":"2007","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"10.1053\/j.seminoncol.2024.05.001_bib0062","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/S0046-8177(75)80099-2","article-title":"Histologic variants of infiltrating lobular carcinoma of the breast","volume":"6","author":"Fechner","year":"1975","journal-title":"Hum Pathol"},{"issue":"6","key":"10.1053\/j.seminoncol.2024.05.001_bib0063","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/S0046-8177(77)80096-8","article-title":"Tubulolobular invasive breast cancer: a variant of lobular invasive cancer","volume":"8","author":"Fisher","year":"1977","journal-title":"Hum Pathol"},{"issue":"16","key":"10.1053\/j.seminoncol.2024.05.001_bib0064","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1200\/JCO.2015.64.0334","article-title":"Genomic characterization of primary invasive lobular breast cancer","volume":"34","author":"Desmedt","year":"2016","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1053\/j.seminoncol.2024.05.001_bib0065","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1007\/s10549-012-2002-z","article-title":"Invasive lobular breast cancer: subtypes and outcome","volume":"133","author":"Iorfida","year":"2012","journal-title":"Breast Cancer Res Treat"},{"issue":"7","key":"10.1053\/j.seminoncol.2024.05.001_bib0066","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.prp.2016.05.002","article-title":"Lobular breast cancer: clinical, molecular and morphological characteristics","volume":"212","author":"Christgen","year":"2016","journal-title":"Pathol Res Pract"},{"issue":"15","key":"10.1053\/j.seminoncol.2024.05.001_bib0067","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/cancers13153695","article-title":"Lobular breast cancer: histomorphology and different concepts of a special spectrum of tumors","volume":"13","author":"Christgen","year":"2021","journal-title":"Cancers"},{"issue":"1","key":"10.1053\/j.seminoncol.2024.05.001_bib0068","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJMoa2203690","article-title":"Trastuzumab deruxtecan in previously treated HER2-low advanced breast cancer","volume":"387","author":"Modi","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminoncol.2024.05.001_bib0069","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.humpath.2020.01.003","article-title":"The updated 2018 American Society of Clinical Oncology\/College of American Pathologists guideline on human epidermal growth factor receptor 2 interpretation in breast cancer: comparison with previous guidelines and clinical significance of the proposed in","volume":"98","author":"Woo","year":"2020","journal-title":"Hum Pathol"},{"issue":"349","key":"10.1053\/j.seminoncol.2024.05.001_bib0070","first-page":"345","article-title":"HER-2 low status in early-stage invasive lobular carcinoma of the breast: associated factors and outcomes in an institutional series","volume":"199","author":"Rothschild","year":"2023","journal-title":"Breast Cancer Res Treat"},{"issue":"7","key":"10.1053\/j.seminoncol.2024.05.001_bib0071","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1002\/cncr.23811","article-title":"Clinicopathologic characteristics of invasive lobular carcinoma of the breast: results of an analysis of 530 cases from a single institution","volume":"113","author":"Orvieto","year":"2008","journal-title":"Cancer"},{"issue":"7","key":"10.1053\/j.seminoncol.2024.05.001_bib0072","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1093\/jnci\/djx268","article-title":"Immune infiltration in invasive lobular breast cancer","volume":"110","author":"Desmedt","year":"2018","journal-title":"J Natl Cancer Inst"},{"issue":"22","key":"10.1053\/j.seminoncol.2024.05.001_bib0073","doi-asserted-by":"crossref","first-page":"4847","DOI":"10.1002\/cncr.33104","article-title":"Differential impact of prognostic parameters in hormone receptor\u2013positive lobular breast cancer","volume":"126","author":"Christgen","year":"2020","journal-title":"Cancer"},{"key":"10.1053\/j.seminoncol.2024.05.001_bib0074","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1016\/S0959-8049(20)30542-6","article-title":"Clinical utility of MammaPrint testing in invasive lobular carcinoma: results from the MINDACT phase III trial","volume":"138","author":"Metzger","year":"2020","journal-title":"Eur J Cancer"},{"issue":"2","key":"10.1053\/j.seminoncol.2024.05.001_bib0075","first-page":"191","article-title":"Inter-observer agreement for the histological diagnosis of invasive lobular breast carcinoma","volume":"8","author":"Christgen","year":"2022","journal-title":"J Pathol"},{"issue":"10","key":"10.1053\/j.seminoncol.2024.05.001_bib0076","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1038\/modpathol.2008.106","article-title":"Interobserver variability and aberrant E-cadherin immunostaining of lobular neoplasia and infiltrating lobular carcinoma","volume":"21","author":"Choi","year":"2008","journal-title":"Mod Pathol"},{"issue":"11","key":"10.1053\/j.seminoncol.2024.05.001_bib0077","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1038\/s41379-019-0294-9","article-title":"E-cadherin clone 36 nuclear staining dictates adverse disease outcome in lobular breast cancer patients","volume":"32","author":"Lobo","year":"2019","journal-title":"Mod Pathol"},{"key":"10.1053\/j.seminoncol.2024.05.001_bib0078","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.humpath.2020.06.002","article-title":"E-cadherin immunohistochemical expression in invasive lobular carcinoma of the breast: correlation with morphology and CDH1 somatic alterations","volume":"102","author":"Grabenstetter","year":"2020","journal-title":"Hum Pathol"},{"issue":"3","key":"10.1053\/j.seminoncol.2024.05.001_bib0079","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1097\/PAS.0000000000001822","article-title":"Expression of N-terminal-deficient E-cadherin protein in invasive lobular carcinoma of the breast","volume":"46","author":"Yasui","year":"2022","journal-title":"Am J Surg Pathol"},{"issue":"7","key":"10.1053\/j.seminoncol.2024.05.001_bib0080","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1038\/s41379-019-0209-9","article-title":"The molecular mechanisms underlying reduced E-cadherin expression in invasive ductal carcinoma of the breast: high throughput analysis of large cohorts","volume":"32","author":"Alsaleem","year":"2019","journal-title":"Mod Pathol"},{"key":"10.1053\/j.seminoncol.2024.05.001_bib0081","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1053\/j.seminoncol.2019.03.002","article-title":"Invasive lobular breast cancer: a review of pathogenesis, diagnosis, management, and future directions of early-stage disease","volume":"46","author":"Thomas","year":"2019","journal-title":"Semin Oncol"},{"key":"10.1053\/j.seminoncol.2024.05.001_bib0082","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1148\/radiol.2333031484","article-title":"Diagnostic accuracy of mammography, clinical examination, US, and MR imaging in preoperative assessment of breast cancer","volume":"233","author":"Berg","year":"2014","journal-title":"Radiology"},{"key":"10.1053\/j.seminoncol.2024.05.001_bib0083","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1148\/radiology.178.1.1984294","article-title":"Invasive lobular carcinoma: mammographic findings in a 10-year experience","volume":"178","author":"Hilleren","year":"1991","journal-title":"Radiology"},{"key":"10.1053\/j.seminoncol.2024.05.001_bib0084","doi-asserted-by":"crossref","first-page":"957","DOI":"10.2214\/ajr.161.5.8273634","article-title":"Invasive lobular carcinoma of the breast: mammographic findings and extent of disease at diagnosis in 184 patients","volume":"161","author":"Krecke","year":"1993","journal-title":"AJR Am J Roentgenol"},{"key":"10.1053\/j.seminoncol.2024.05.001_bib0085","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1148\/radiology.185.3.1438749","article-title":"Mammographic features of 455 invasive lobular carcinomas","volume":"185","author":"Le Gal","year":"1992","journal-title":"Radiology"},{"issue":"2","key":"10.1053\/j.seminoncol.2024.05.001_bib0086","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1111\/tbj.13191","article-title":"Supplemental ultrasound screening in patients with a history of lobular neoplasia","volume":"25","author":"Phalak","year":"2019","journal-title":"Breast J"},{"issue":"2","key":"10.1053\/j.seminoncol.2024.05.001_bib0087","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s13244-014-0324-6","article-title":"Evolving concepts in breast lobular neoplasia and invasive lobular carcinoma, and their impact on imaging methods","volume":"5","author":"Oliveira","year":"2014","journal-title":"Insights Imaging"},{"issue":"1","key":"10.1053\/j.seminoncol.2024.05.001_bib0088","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1046\/j.1524-4741.2003.09104.x","article-title":"Invasive lobular carcinoma: spectrum of enhancement and morphology on magnetic resonance imaging","volume":"9","author":"Yeh","year":"2003","journal-title":"Breast J"},{"issue":"1","key":"10.1053\/j.seminoncol.2024.05.001_bib0089","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1002\/jso.25130","article-title":"Predictive value of breast magnetic resonance imaging in detecting mammographically occult contralateral breast cancer: can we target women more likely to have contralateral breast cancer?","volume":"118","author":"Susnik","year":"2018","journal-title":"J Surg Oncol"},{"issue":"6","key":"10.1053\/j.seminoncol.2024.05.001_bib0090","doi-asserted-by":"crossref","first-page":"867","DOI":"10.3390\/jpm12060867","article-title":"Diagnostic challenge of invasive lobular carcinoma of the breast: what is the news? Breast magnetic resonance imaging and emerging role of contrast-enhanced spectral mammography","volume":"12","author":"Costantini","year":"2022","journal-title":"J Pers Med"},{"key":"10.1053\/j.seminoncol.2024.05.001_bib0091","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejrad.2023.110881","article-title":"The performance of contrast-enhanced mammography and breast MRI in local preoperative staging of invasive lobular breast cancer","volume":"164","author":"Lobbes","year":"2023","journal-title":"Eur J Radiol"},{"issue":"10","key":"10.1053\/j.seminoncol.2024.05.001_bib0092","doi-asserted-by":"crossref","first-page":"5723","DOI":"10.1245\/s10434-021-10455-7","article-title":"Invasive lobular breast cancer: data to support surgical decision making","volume":"28","author":"Cocco","year":"2021","journal-title":"Ann Surg Oncol"},{"issue":"7","key":"10.1053\/j.seminoncol.2024.05.001_bib0093","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1245\/s10434-010-0953-z","article-title":"Invasive lobular vs. ductal breast cancer: a stage-matched comparison of outcomes","volume":"17","author":"Wasif","year":"2010","journal-title":"Ann Surg Oncol"},{"issue":"10","key":"10.1053\/j.seminoncol.2024.05.001_bib0094","doi-asserted-by":"crossref","first-page":"3397","DOI":"10.1245\/s10434-015-4756-0","article-title":"The importance of applying ACOSOG Z0011 criteria in the axillary management of invasive lobular carcinoma: a multi-institutional cohort study","volume":"22","author":"Roberts","year":"2015","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"10.1053\/j.seminoncol.2024.05.001_bib0095","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1097\/00000658-199522240-00012","article-title":"Tumor biology of infiltrating lobular carcinoma. Implications for management","volume":"222","author":"Yeatman","year":"1995","journal-title":"Ann Surg"},{"issue":"1","key":"10.1053\/j.seminoncol.2024.05.001_bib0096","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1200\/JCO.2005.03.111","article-title":"Invasive lobular carcinoma classic type: response to primary chemotherapy and survival outcomes","volume":"23","author":"Cristofanilli","year":"2005","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1053\/j.seminoncol.2024.05.001_bib0097","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.amjsurg.2021.05.021","article-title":"Positive margins after mastectomy in patients with invasive lobular carcinoma of the breast: incidence and management strategies","volume":"223","author":"Hewitt","year":"2022","journal-title":"Am J Surg"},{"issue":"1","key":"10.1053\/j.seminoncol.2024.05.001_bib0098","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/s41523-019-0125-7","article-title":"Success rates of re-excision after positive margins for invasive lobular carcinoma of the breast","volume":"5","author":"Piper","year":"2019","journal-title":"npj Breast Cancer"},{"key":"10.1053\/j.seminoncol.2024.05.001_bib0099","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.breast.2021.11.017","article-title":"Differences in sensitivity to neoadjuvant chemotherapy among invasive lobular and ductal carcinoma of the breast and implications on surgery\u2014a systematic review and meta-analysis","volume":"61","author":"O'Connor","year":"2022","journal-title":"Breast"},{"issue":"5","key":"10.1053\/j.seminoncol.2024.05.001_bib0100","first-page":"e38399","article-title":"Risk factors for positive margins in breast-conserving surgery","volume":"15","author":"Abdulla","year":"2023","journal-title":"Cureus"},{"issue":"9","key":"10.1053\/j.seminoncol.2024.05.001_bib0101","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1177\/000313480407000915","article-title":"Breast conservation therapy for invasive lobular carcinoma: the impact of lobular carcinoma in situ in the surgical specimen on local recurrence and axillary node status","volume":"70","author":"Stolier","year":"2004","journal-title":"Am Surg"},{"issue":"7","key":"10.1053\/j.seminoncol.2024.05.001_bib0102","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1007\/BF02305534","article-title":"Optimal surgical treatment of invasive lobular carcinoma of the breast","volume":"4","author":"Chung","year":"1997","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"10.1053\/j.seminoncol.2024.05.001_bib0103","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.ejso.2014.09.004","article-title":"Surgical management of lobular carcinoma from a national screening program: a retrospective analysis","volume":"41","author":"Sharma","year":"2015","journal-title":"Eur J Surg Oncol"},{"issue":"5","key":"10.1053\/j.seminoncol.2024.05.001_bib0104","doi-asserted-by":"crossref","first-page":"2555","DOI":"10.1245\/s10434-020-09042-z","article-title":"Oncological outcomes of total skin-sparing mastectomy for invasive lobular carcinoma of the breast: a 20-year institutional experience","volume":"28","author":"Son","year":"2021","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"10.1053\/j.seminoncol.2024.05.001_bib0105","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1097\/01.sla.0000171306.74366.22","article-title":"Treatment trends in early-stage invasive lobular carcinoma: a report from the National Cancer Data Base","volume":"242","author":"Singletary","year":"2005","journal-title":"Annals Surg"},{"issue":"1","key":"10.1053\/j.seminoncol.2024.05.001_bib0106","doi-asserted-by":"crossref","first-page":"e101","DOI":"10.1016\/j.clbc.2018.10.010","article-title":"Long-term survival differences between T1-2 invasive lobular breast cancer and corresponding ductal carcinoma after breast-conserving surgery: a propensity-scored matched longitudinal cohort study","volume":"19","author":"Wang","year":"2019","journal-title":"Clin Breast Cancer"},{"issue":"12","key":"10.1053\/j.seminoncol.2024.05.001_bib0107","doi-asserted-by":"crossref","first-page":"3856","DOI":"10.1245\/s10434-019-07751-8","article-title":"Was reexcision less frequent for patients with lobular breast cancer after publication of the SSO-ASTRO margin guidelines?","volume":"26","author":"Mamtani","year":"2019","journal-title":"Ann Surg Oncol"},{"key":"10.1053\/j.seminoncol.2024.05.001_bib0108","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.crad.2015.10.030","article-title":"Contralateral breast cancer: incidence according to ductal or lobular phenotype of the primary","volume":"71","author":"Langlands","year":"2016","journal-title":"Clin Radiol"},{"key":"10.1053\/j.seminoncol.2024.05.001_bib0109","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1007\/s10549-020-06047-w","article-title":"Is axillary imaging for invasive lobular carcinoma accurate in determining clinical node staging?","volume":"185","author":"Schumacher","year":"2021","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"10.1053\/j.seminoncol.2024.05.001_bib0110","doi-asserted-by":"crossref","first-page":"63","DOI":"10.4048\/jbc.2015.18.1.63","article-title":"Effectiveness of breast MRI and (18)F-FDG PET\/CT for the preoperative staging of invasive lobular carcinoma versus ductal carcinoma","volume":"18","author":"Jung","year":"2015","journal-title":"J Breast Cancer"},{"issue":"1","key":"10.1053\/j.seminoncol.2024.05.001_bib0111","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s13058-015-0519-x","article-title":"Invasive lobular carcinoma of the breast: morphology, biomarkers and 'omics","volume":"17","author":"McCart Reed","year":"2015","journal-title":"Breast Cancer Res"},{"issue":"3","key":"10.1053\/j.seminoncol.2024.05.001_bib0112","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1007\/s10549-020-05794-0","article-title":"Evaluating the impact of axillary dissection on recurrence-free survival by extent of nodal disease in invasive lobular carcinoma of the breast","volume":"183","author":"Abel","year":"2020","journal-title":"Breast Cancer Res Treat"},{"issue":"4","key":"10.1053\/j.seminoncol.2024.05.001_bib0113","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1111\/tbj.14161","article-title":"Accuracy of sentinel lymph node biopsy in invasive lobular carcinoma of the breast: factors associated with false negatives","volume":"27","author":"Mukhtar","year":"2021","journal-title":"Breast J"},{"issue":"2","key":"10.1053\/j.seminoncol.2024.05.001_bib0114","doi-asserted-by":"crossref","first-page":"e89778","DOI":"10.1371\/journal.pone.0089778","article-title":"Outcomes of sentinel lymph node dissection alone vs. axillary lymph node dissection in early-stage invasive lobular carcinoma: a retrospective study of the surveillance, epidemiology and end results (SEER) database","volume":"9","author":"Wang","year":"2014","journal-title":"PLoS One"},{"key":"10.1053\/j.seminoncol.2024.05.001_bib0115","doi-asserted-by":"crossref","first-page":"3166","DOI":"10.1245\/s10434-019-07564-9","article-title":"Neoadjuvant endocrine therapy versus neoadjuvant chemotherapy in node-positive invasive lobular carcinoma","volume":"26","author":"Thornton","year":"2019","journal-title":"Ann Surg Oncol"},{"key":"10.1053\/j.seminoncol.2024.05.001_bib0116","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.amjsurg.2017.11.011","article-title":"Neoadjuvant systemic therapy in invasive lobular breast cancer: is it indicated?","volume":"215","author":"Tsung","year":"2018","journal-title":"Am J Surg"},{"issue":"3","key":"10.1053\/j.seminoncol.2024.05.001_bib0117","doi-asserted-by":"crossref","first-page":"R149","DOI":"10.1186\/bcr767","article-title":"Infiltrating lobular carcinoma of the breast: tumor characteristics and clinical outcome","volume":"6","author":"Arpino","year":"2004","journal-title":"Breast Cancer Res"},{"issue":"3","key":"10.1053\/j.seminoncol.2024.05.001_bib0118","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.critrevonc.2014.07.003","article-title":"Invasive lobular breast cancer and its variants: how special are they for systemic therapy decisions?","volume":"92","author":"Guiu","year":"2014","journal-title":"Crit Rev Oncol Hematol"},{"issue":"5","key":"10.1053\/j.seminoncol.2024.05.001_bib0119","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1111\/tbj.12455","article-title":"Comparative long-term study of a large series of patients with invasive ductal carcinoma and invasive lobular carcinoma. Loco-regional recurrence, metastasis, and survival","volume":"21","author":"Garcia-Fernandez","year":"2015","journal-title":"Breast J"},{"issue":"3","key":"10.1053\/j.seminoncol.2024.05.001_bib0120","doi-asserted-by":"crossref","first-page":"285","DOI":"10.4048\/jbc.2015.18.3.285","article-title":"Comparison of clinicopathological features and treatment results between invasive lobular carcinoma and ductal carcinoma of the breast","volume":"18","author":"Park","year":"2015","journal-title":"J Breast Cancer"},{"issue":"4","key":"10.1053\/j.seminoncol.2024.05.001_bib0121","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1245\/s10434-011-1907-9","article-title":"Lobular breast cancer: same survival and local control compared with ductal cancer, but should both be treated the same way? Analysis of an institutional database over a 10-year period","volume":"19","author":"Fortunato","year":"2012","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"10.1053\/j.seminoncol.2024.05.001_bib0122","doi-asserted-by":"crossref","first-page":"22","DOI":"10.5152\/ejbh.2019.5004","article-title":"A comparison of the clinicopathological features, metastasis sites and survival outcomes of invasive lobular, invasive ductal and mixed invasive ductal and lobular breast carcinoma","volume":"16","author":"Duraker","year":"2020","journal-title":"Eur J Breast Health"},{"issue":"1","key":"10.1053\/j.seminoncol.2024.05.001_bib0123","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ejca.2007.10.009","article-title":"Invasive lobular carcinoma of the breast: response to hormonal therapy and outcomes","volume":"44","author":"Rakha","year":"2008","journal-title":"Eur J Cancer"},{"issue":"3","key":"10.1053\/j.seminoncol.2024.05.001_bib0124","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/his.12572","article-title":"Invasive lobular breast cancer: the prognostic impact of histopathological grade, E-cadherin and molecular subtypes","volume":"66","author":"Engstr\u00f8m","year":"2015","journal-title":"Histopathology"},{"key":"10.1053\/j.seminoncol.2024.05.001_bib0125","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1186\/s12885-016-2275-4","article-title":"Comparison of clinical outcomes between luminal invasive ductal carcinoma and luminal invasive lobular carcinoma","volume":"16","author":"Adachi","year":"2016","journal-title":"BMC Cancer"},{"issue":"11","key":"10.1053\/j.seminoncol.2024.05.001_bib0126","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1093\/jnci\/djac157","article-title":"Clinicopathological features and outcomes comparing patients with invasive ductal and lobular breast cancer","volume":"114","author":"Oesterreich","year":"2022","journal-title":"J Natl Cancer Inst"},{"key":"10.1053\/j.seminoncol.2024.05.001_bib0127","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2024.102552","article-title":"Comparison of long-term outcome between clinically high risk lobular versus ductal breast cancer: a propensity score matched study","volume":"71","author":"Magnoni","year":"2024","journal-title":"EClinicalMedicine"},{"key":"10.1053\/j.seminoncol.2024.05.001_bib0128","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s10549-012-2233-z","article-title":"Lobular histology and response to neoadjuvant chemotherapy in invasive breast cancer","volume":"136","author":"Lips","year":"2012","journal-title":"Breast Cancer Res Treat"},{"key":"10.1053\/j.seminoncol.2024.05.001_bib0129","doi-asserted-by":"crossref","first-page":"3036","DOI":"10.3390\/cancers13123036","article-title":"Survival outcomes in invasive lobular carcinoma compared to oestrogen receptor-positive invasive ductal carcinoma","volume":"13","author":"Timbres","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1053\/j.seminoncol.2024.05.001_bib0130","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1053\/ejso.2002.1404","article-title":"Different responses to preoperative chemotherapy for invasive lobular and invasive ductal breast carcinoma","volume":"29","author":"Cocquyt","year":"2003","journal-title":"Eur J Sur Oncol"},{"key":"10.1053\/j.seminoncol.2024.05.001_bib0131","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1093\/annonc\/mdl114","article-title":"Response to neoadjuvant chemotherapy in lobular and ductal breast carcinomas: a retrospective study on 860 patients from one institution","volume":"17","author":"Tubiana-Hulin","year":"2006","journal-title":"Ann Oncol"},{"key":"10.1053\/j.seminoncol.2024.05.001_bib0132","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/bjc.2012.557","article-title":"Clinical benefit from neoadjuvant chemotherapy in oestrogen receptor-positive invasive ductal and lobular carcinomas","volume":"108","author":"Delpech","year":"2013","journal-title":"Br J Cancer"},{"key":"10.1053\/j.seminoncol.2024.05.001_bib0133","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1007\/s10549-011-1735-4","article-title":"Invasive lobular carcinoma: response to neoadjuvant letrozole therapy","volume":"130","author":"Dixon","year":"2011","journal-title":"Breast Cancer Res Treat"},{"key":"10.1053\/j.seminoncol.2024.05.001_bib0134","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.1093\/annonc\/mdy448","article-title":"Letrozole and palbociclib versus chemotherapy as neoadjuvant therapy of high-risk luminal breast cancer","volume":"29","author":"Cottu","year":"2018","journal-title":"Ann Oncol"},{"key":"10.1053\/j.seminoncol.2024.05.001_bib0135","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S1470-2045(19)30786-7","article-title":"Ribociclib plus letrozole versus chemotherapy for postmenopausal women with hormone receptor-positive, HER2-negative, luminal B breast cancer (CORALLEEN): an open-label, multicentre, randomised, phase 2 trial","volume":"21","author":"Prat","year":"2020","journal-title":"Lancet Oncol"},{"key":"10.1053\/j.seminoncol.2024.05.001_bib0136","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1056\/NEJMoa2112651","article-title":"Event-free survival with pembrolizumab in early triple-negative breast cancer","volume":"386","author":"Schmid","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminoncol.2024.05.001_bib0137","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/s43018-023-00542-x","article-title":"PD-L1 blockade in combination with carboplatin as immune induction in metastatic lobular breast cancer: the GELATO trial","volume":"4","author":"Voorwerk","year":"2023","journal-title":"Nat Cancer"},{"key":"10.1053\/j.seminoncol.2024.05.001_bib0138","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2021.102205","article-title":"Benefit of adjuvant chemotherapy in patients with lobular breast cancer: a systematic review of the literature and metanalysis","volume":"97","author":"Trapani","year":"2021","journal-title":"Cancer Treat Rev"},{"key":"10.1053\/j.seminoncol.2024.05.001_bib0139","article-title":"Efficacy of chemotherapy in patients with HR+\/HER2\u2013invasive lobular breast cancer","volume":"34","author":"Yaghi","year":"2023","journal-title":"Cancer Treat Res Commun"},{"key":"10.1053\/j.seminoncol.2024.05.001_bib0140","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s10549-019-05160-9","article-title":"Adjuvant chemotherapy in lobular carcinoma of the breast: a clinicopathological score identifies high-risk patient with survival benefit","volume":"175","author":"De Nonneville","year":"2019","journal-title":"Breast Cancer Res Treat"},{"key":"10.1053\/j.seminoncol.2024.05.001_bib0141","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1002\/jso.25492","article-title":"The impact of chemotherapy sequence on survival in node-positive invasive lobular carcinoma","volume":"120","author":"Tamirisa","year":"2019","journal-title":"J Surg Oncol"},{"issue":"554","key":"10.1053\/j.seminoncol.2024.05.001_bib0142","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1200\/JCO.2023.41.16_suppl.554","article-title":"SEER analysis of 9-year breast cancer specific mortality (BCSM) in patients (pts) with invasive lobular breast cancer (ILC) assessed by the 21-gene Breast Recurrence Score assay","volume":"41","author":"Geyer","year":"2023","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2024.05.001_bib0143","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1016\/S0140-6736(18)33137-4","article-title":"Increasing the dose intensity of chemotherapy by more frequent administration or sequential scheduling: a patient-level meta-analysis of 37\u2008298 women with early breast cancer in 26 randomised trials","volume":"393","author":"Gray","year":"2019","journal-title":"Lancet"},{"key":"10.1053\/j.seminoncol.2024.05.001_bib0144","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1200\/JCO.2008.18.4028","article-title":"Docetaxel with cyclophosphamide is associated with an overall survival benefit compared with doxorubicin and cyclophosphamide: 7-year follow-up of US oncology research trial 9735","volume":"27","author":"Jones","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2024.05.001_bib0145","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1200\/JCO.18.00028","article-title":"West German Study PlanB Trial: adjuvant four cycles of epirubicin and cyclophosphamide plus docetaxel versus six cycles of docetaxel and cyclophosphamide in HER2-negative early breast cancer","volume":"37","author":"Nitz","year":"2019","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2024.05.001_bib0146","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1038\/s41416-021-01690-6","article-title":"The impact of anthracyclines in intermediate and high-risk HER2-negative early breast cancer\u2014a pooled analysis of the randomised clinical trials PlanB and SUCCESS C","volume":"126","author":"De Gregorio","year":"2022","journal-title":"Br J Cancer"},{"key":"10.1053\/j.seminoncol.2024.05.001_bib0147","doi-asserted-by":"crossref","first-page":"2772","DOI":"10.1200\/JCO.2015.60.8133","article-title":"Relative effectiveness of letrozole compared with tamoxifen for patients with lobular carcinoma in the BIG 1-98 trial","volume":"33","author":"Metzger Filho","year":"2015","journal-title":"J Clin Oncol"},{"issue":"9_suppl","key":"10.1053\/j.seminoncol.2024.05.001_bib0148","article-title":"Abstract S2-06: survival advantage of anastrozol compared to tamoxifen for lobular breast cancer in the ABCSG-8 study","volume":"75","author":"Knauer","year":"2015","journal-title":"Cancer Res"},{"key":"10.1053\/j.seminoncol.2024.05.001_bib0149","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.ejca.2017.11.014","article-title":"Outcomes in women with invasive ductal or invasive lobular early-stage breast cancer treated with anastrozole or exemestane in CCTG (NCIC CTG) MA.27","volume":"90","author":"Strasser-Weippl","year":"2018","journal-title":"Eur J Cancer"},{"key":"10.1053\/j.seminoncol.2024.05.001_bib0150","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/S1470-2045(21)00758-0","article-title":"Aromatase inhibitors versus tamoxifen in premenopausal women with oestrogen receptor-positive early-stage breast cancer treated with ovarian suppression: a patient-level meta-analysis of 7030 women from four randomised trials","volume":"23","author":"Bradley","year":"2022","journal-title":"Lancet Oncol"},{"key":"10.1053\/j.seminoncol.2024.05.001_bib0151","doi-asserted-by":"crossref","DOI":"10.1158\/1538-7445.SABCS21-PD14-08","article-title":"Abstract PD14-08: effectiveness of aromatase inhibitors versus tamoxifen in lobular compared to ductal carcinoma: individual patient data meta-analysis of 9328 women with central histopathology, and 7654 women with e-Cadherin status","volume":"82","author":"Hills","year":"2022","journal-title":"Cancer Res"},{"key":"10.1053\/j.seminoncol.2024.05.001_bib0152","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1093\/annonc\/mdz173","article-title":"Early breast cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up","volume":"30","author":"Cardoso","year":"2019","journal-title":"Ann Oncol"},{"key":"10.1053\/j.seminoncol.2024.05.001_bib0153","doi-asserted-by":"crossref","first-page":"73337","DOI":"10.18632\/oncotarget.11819","article-title":"ERBB2 mutations associated with solid variant of high-grade invasive lobular breast carcinomas","volume":"7","author":"Deniziaut","year":"2016","journal-title":"Oncotarget"},{"key":"10.1053\/j.seminoncol.2024.05.001_bib0154","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1002\/cncr.21921","article-title":"Selecting patients for breast-conserving therapy: the importance of lobular histology","volume":"106","author":"Morrow","year":"2006","journal-title":"Cancer"},{"key":"10.1053\/j.seminoncol.2024.05.001_bib0155","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1002\/cncr.21071","article-title":"Similar long-term results of breast-conservation treatment for stage I and II invasive lobular carcinoma compared with invasive ductal carcinoma of the breast: the University of Pennsylvania experience","volume":"103","author":"Santiago","year":"2005","journal-title":"Cancer"},{"key":"10.1053\/j.seminoncol.2024.05.001_bib0156","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s10549-006-9431-5","article-title":"Margin status and the risk of local recurrence after breast-conserving treatment of lobular breast cancer","volume":"105","author":"Van den Broek","year":"2007","journal-title":"Breast Cancer Res Treat"},{"key":"10.1053\/j.seminoncol.2024.05.001_bib0157","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/0277-5379(90)90115-A","article-title":"Local control of operable breast cancer after radiotherapy alone","volume":"26","author":"Van Limbergen","year":"1990","journal-title":"Eur J Cancer"},{"key":"10.1053\/j.seminoncol.2024.05.001_bib0158","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1093\/annonc\/mdu090","article-title":"Tumor factors predictive of response to hypofractionated radiotherapy in a randomized trial following breast conserving therapy","volume":"25","author":"Bane","year":"2014","journal-title":"Ann Oncol"},{"key":"10.1053\/j.seminoncol.2024.05.001_bib0159","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1200\/JCO.2014.55.1572","article-title":"Margins for breast-conserving surgery with whole-breast irradiation in stage I and II invasive breast cancer: American Society of Clinical Oncology endorsement of the Society of Surgical Oncology\/American Society for Radiation Oncology consensus guideline","volume":"32","author":"Buchholz","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2024.05.001_bib0160","doi-asserted-by":"crossref","first-page":"284","DOI":"10.5301\/tj.5000500","article-title":"Surgical resection margins after breast-conserving surgery: Senonetwork recommendations","volume":"2016","author":"Galimberti","year":"2016","journal-title":"Tumori"},{"key":"10.1053\/j.seminoncol.2024.05.001_bib0161","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.clbc.2016.02.001","article-title":"Post-mastectomy radiation therapy for invasive lobular carcinoma: a comparative utilization and outcomes study","volume":"16","author":"Stecklein","year":"2016","journal-title":"Clin Breast Cancer"},{"key":"10.1053\/j.seminoncol.2024.05.001_bib0162","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1200\/JCO.2001.19.6.1688","article-title":"Differences in risk factors for local and distant recurrence after breast-conserving therapy or mastectomy for stage I and II breast cancer: pooled results of two large European randomized trials","volume":"19","author":"Voogd","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2024.05.001_bib0163","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.radonc.2012.12.010","article-title":"Infiltrating lobular breast cancer: truly a separate entity! Consequences for radiation therapy","volume":"106","author":"Poortmans","year":"2013","journal-title":"Radiother Oncol"},{"key":"10.1053\/j.seminoncol.2024.05.001_bib0164","doi-asserted-by":"crossref","first-page":"4479","DOI":"10.1200\/JCO.2011.36.1667","article-title":"Positive sentinel nodes without axillary dissection: implications for the radiation oncologist","volume":"29","author":"Haffty","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2024.05.001_bib0165","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1111\/tbj.13851","article-title":"Feasibility and surgical impact of Z0011 trial criteria in a single-Institution practice","volume":"26","author":"Morigi","year":"2020","journal-title":"Breast J"},{"key":"10.1053\/j.seminoncol.2024.05.001_bib0166","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ejso.2019.08.013","article-title":"Management of the axilla in patients with breast cancer and positive sentinel lymph node biopsy: an evidence-based update in a European breast center","volume":"46","author":"Garcia-Etienne","year":"2020","journal-title":"Eur J Surg Oncol"},{"key":"10.1053\/j.seminoncol.2024.05.001_bib0167","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.semradonc.2022.01.006","article-title":"Tailoring the omission of radiotherapy for early-stage breast cancer based on tumor biology","volume":"32","author":"Allen","year":"2022","journal-title":"Semin Radiat Oncol"},{"key":"10.1053\/j.seminoncol.2024.05.001_bib0168","doi-asserted-by":"crossref","first-page":"5999","DOI":"10.1245\/s10434-023-13881-x","article-title":"Predictors of early versus late recurrence in invasive lobular carcinoma of the breast: impact of local and systemic therapy","volume":"30","author":"Rothschild","year":"2023","journal-title":"Ann Surg Oncol"},{"key":"10.1053\/j.seminoncol.2024.05.001_bib0169","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.prro.2016.09.007","article-title":"Accelerated partial breast irradiation: executive summary for the update of an ASTRO evidence-based consensus statement","volume":"7","author":"Correa","year":"2017","journal-title":"Pract Radiat Oncol"},{"key":"10.1053\/j.seminoncol.2024.05.001_bib0170","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.radonc.2010.01.014","volume":"94","author":"Polg\u00e1r","year":"2010","journal-title":"Radiother Oncol"},{"key":"10.1053\/j.seminoncol.2024.05.001_bib0171","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.brachy.2013.02.001","article-title":"The American Brachytherapy Society consensus statement for accelerated partial breast irradiation","volume":"12","author":"Shah","year":"2013","journal-title":"Brachytherapy"},{"key":"10.1053\/j.seminoncol.2024.05.001_bib0172","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.clbc.2020.04.003","article-title":"Update on partial breast irradiation","volume":"21","author":"Hepel","year":"2021","journal-title":"Clin Breast Cancer"},{"key":"10.1053\/j.seminoncol.2024.05.001_bib0173","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.ijrobp.2017.04.033","article-title":"Comparison of treatment outcome between invasive lobular and ductal carcinomas in patients receiving partial breast irradiation with intraoperative electrons","volume":"99","author":"Leonardi","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Seminars in Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0093775424000381?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0093775424000381?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T05:08:34Z","timestamp":1722488914000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0093775424000381"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":173,"journal-issue":{"issue":"3-4","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["S0093775424000381"],"URL":"https:\/\/doi.org\/10.1053\/j.seminoncol.2024.05.001","relation":{},"ISSN":["0093-7754"],"issn-type":[{"value":"0093-7754","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Invasive lobular breast cancer: Focus on prevention, genetics, diagnosis, and treatment","name":"articletitle","label":"Article Title"},{"value":"Seminars in Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.seminoncol.2024.05.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}